Evaluation of antihyperlipidemic and antioxidant activity of Rubia Cordifolia Linn.
Abstract
Hyperlipidemia is major problem among population those, who have sedentary life style. The effects of ethanolic and aqueous root extract of Rubiacordifoliain experimentally induced hyperlipidemic rats were investigated. 42 wistar rats of both sexes were used for the study. The animals were completely randomized into seven groups comprising 6 animals each. The groups were treated as follows: Group I: normal diet (ND); Group II: HFD ( Vanaspati ghee + coconut oil mixture in ratio of 3:2 at 10 ml/kg/day); Group III: HFD + Atorvastatin (10 mg/kg/day); Group IV: HFD+ ethanolic extract of roots of Rubia cordifolia low dose(200 mg/kg/day); Group V: HFD + ethanolic extract of roots of Rubia cordifolia high dose (400 mg/kg/day); Group VI: HFD + aqueous extract of roots of Rubia cordifolia low dose (200 mg/kg/day); Group VII: HFD + aqueous extract of roots of Rubia cordifolia high dose (400 mg/kg/day). Hypercholesterolemia was induced by feeding the animals with high fat diet for 21 days before administration of the extract. After 21thday of feeding, administration of extract lasted for 14 days. Preliminary phytochemical screening revealed that the ethanolic and aqueous root extract of Rubia cordifolia contains glycosides, triterpenoids, saponins, alkaloids and flavonoids. Overall, findings from the present study suggest that the antihyperlipidemic activity observed with Atorvastatin (10mg/kg oral) and the ethanolic extracts of Rubia cordifolia (400mg/kg) showed better activity thanaqueous extracts of Rubia cordifolia (200mg/kg).
Keywords: Rubia cordifolia, body weight, high fat diet, serum lipid, anti-hyperlipidemic activity.
DOI
https://doi.org/10.22270/jddt.v9i1.2216References
Yusuf S, Reddy S, Ounpuu, S, Anand, S., Global burden of cardiovascular diseases: Part I: General Considerations, The Epidemiologic Transition, risk factors, and impact of urbanization. Circulation, 2001; 104:2746-3.
Ahmad N, Bhopal R., A systematic review based on ECG defined coronary heart disease. Heart, 2005; 91:719-5.
Zhang R, Ma J, Xia M, Zhu H, Ling W., Hyperhomocysteinemia induced by feeding rats diet rich in methionine or deficient in folate promotes early atherosclerotic inflammatory process. J Nutr, 2004; 134(4):825-0.
Raman Jegadeesha b, NanjianRaamana, et al., Hypolipidemic Effect of Pleurotusdjamor var. roseus in Experimentally Induced Hypercholesteromic Rats.RJPBCS., 2014; 5(2):581-587.
Ross R, Harker L., Hyperlipidemia and atherosclerosis. Sci., 1976; 193(4258):1094-0.
Kovanen PT, Pentikainen MO., Pharmacologic prevention of coronary plaque rupture - the major cause of acute coronary syndromes. Heart Metab, 2007; 36:9-4.
Potter K., The effect of long-term homocysteine-lowering on carotid intima-media thickness and flow-mediated vasodilation in stroke patients: a randomized controlled trial and meta-analysis. Cardiovasc Dis, 2008; 8:24-7.
Refsum H, Ueland PM., Homocysteine and cardiovascular disease, Ann Rev Med, 1998; 49:31-2.
Khan KH., Roles of Emblicaofficinalis in medicine-a review, Botany Res Int, 2009; 2(4):218-8.
Subramaniam S, Subramaniam R, Rajapandian S., Anti-atherogenicactivity of ethanolic fraction of TerminaliaArjuna bark on hypercholesterolemic rabbits. Evid Based Complement Altern Med, 2010; 1-9.
Carew TE, Schwence DC, Steinberg D., Antiatherogenic effect of probucol unrelated to its hypocholesterolemic effect, ProcNatlAcadSci USA, 1987; 84(21):725-9.
PourushBadal, RajendramaniBadal, Hypolipidemic activity of Petroselinumcripsum Plant in Triton-Wr 1339 Induced Hyperlipidemic Rats.Herbal Tech Industry, 2011; 10-15.
Kapoor P, Ansari, MN, Bhandari U., Modulatory effect of curcumin on methionine-induced hyperlipidemia and hyperhomocysteinemia in albino rats. Ind J Exp Bio, 2008; 46(7):534-0.
Stein JH, McBride PE., Hyperhomocysteinemia and atherosclerotic vascular disease: pathophysiology, screening and treatment. Arch Intern Med, 1998; 158(12):1301-6.
Published
Abstract Display: 542 
PDF Downloads: 457 How to Cite
Issue
Section
Authors who publish with this journal agree to the following terms:
- Authors retain copyright and grant the journal right of first publication with the work simultaneously licensed under a Creative Commons Attribution-NonCommercial 4.0 International (CC BY-NC 4.0). that allows others to share the work with an acknowledgment of the work's authorship and initial publication in this journal.
- Authors are able to enter into separate, additional contractual arrangements for the non-exclusive distribution of the journal's published version of the work (e.g., post it to an institutional repository or publish it in a book), with an acknowledgment of its initial publication in this journal.
- Authors are permitted and encouraged to post their work online (e.g., in institutional repositories or on their website) prior to and during the submission process, as it can lead to productive exchanges, as well as earlier and greater citation of published work (See The Effect of Open Access).
How to Cite
.